Studies on therapeutic activity of benzoxazinorifamycin KRM-1648 in combination with other antimicrobial agents and biological response modifiers interferon-gamma and granulocyte-macrophage colony-stimulating factor against M. leprae infection in athymic nude mice. [electronic resource]
- International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association Sep 1997
- 345-51 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
0148-916X
Adoptive Transfer Animals Clofazimine--therapeutic use Dapsone--therapeutic use Drug Therapy, Combination Female Granulocyte-Macrophage Colony-Stimulating Factor--therapeutic use Immunologic Factors--therapeutic use Interferon-gamma--therapeutic use Leprostatic Agents--therapeutic use Leprosy--drug therapy Mice Mice, Inbred BALB C Mice, Nude Ofloxacin--therapeutic use Rifamycins--therapeutic use